). Because we purposely excluded minorities (African Americans and Latinos in America and nonwhites in England), these differences were not solely due to health issues in the minority or immigrant population. Moreover, these disparities in prevalence of chronic illness were also not the consequence of differences between the two countries in conventional risk factors such as smoking, obesity, and drinking-estimates of health disparities were essentially unchanged when we controlled for different levels of these risk factors in America and in England. Models of diabetes prevalence that controlled for both body mass index (BMI) and waist circumference displayed much reduced country differences . However, the extent to which this can be interpreted as an explanation of cross-country diabetes differences is somewhat limited if one views raised waist circumference for a given BMI as part of the fundamental etiology of diabetes. We still have to be able to explain why-for given levels of obesity-Americans have larger waists than the English. All in all, therefore, it remains the case that much of the US-English difference in later life adult health remains unexplained.
In this chapter, we investigate another hypothesis to help us understand underlying reasons for the large American health disadvantage. This hypothesis is that differential prevalence and differential impacts of early life conditions, and particularly childhood health, between England and the United States may have led to differences in subsequent later-life health outcomes. Considerable evidence has emerged that variation in health outcomes at middle and older ages may be traced in part to health and other conditions during childhood (Barker 1997; Case, Lubotsky, and Paxson 2005; Case, Fertig, and Paxson 2005; Currie and Stabile 2003; Smith 2009a, Smith and . In this chapter, we will test whether such variation accounts for important parts of country differences in adult health.
This remainder of this chapter is divided into four sections. The next section describes the data that we will use in this analysis, while the section that follows compares prevalence of childhood illnesses for birth cohorts in the two countries. Section 9.4 summarizes the main results obtained from analytical models relating these childhood illnesses to measures of adult health. The purpose of this analysis is to assess how much of the large differences in illness at middle and older ages in America compared to England can be explained by any differences that prevailed when these people were children and adolescents. The fi nal section of the paper highlights our main conclusions.
Childhood Health Data in the HRS and ELSA
This research uses data from two surveys-the English Longitudinal Survey of Aging (ELSA) and the US Health and Retirement Survey (HRS).
Both surveys collect longitudinal data on health, disability, economic circumstances, work, and well-being from a representative sample of the English and American populations aged fi fty and older. Both ELSA and HRS are widely viewed as strong in the measurement of socioeconomic variables (education, employment, income, wealth) and health (self-reported subjective general health status, prevalence and incidence of physical and mental disease during the post-age fi fty adult years, such as hypertension, heart disease, diabetes, stroke, chronic lung diseases, asthma, arthritis and cancer, and emotional and mental illness including depression), disability and functioning status, and several salient health behaviors (smoking, alcohol consumption, and physical activity). The HRS and ELSA have both been widely used in stand-alone studies as well as comparative studies of adult health.
One limitation of ELSA and HRS, along with the various other new international aging data sets, is that data collection only begins at age fi fty (and even later for those cohorts who were older at the time of the initial baseline interview). Fortunately, this limitation was recognized, and many of these data sets subsequently fi elded questionnaires or questionnaire modules that aimed to fi ll in, through retrospective recall, the more salient episodes in respondents' prebaseline life histories. Childhood events including childhood health were an important part of these life history interviews.
Both the HRS and ELSA included very similar retrospectively reported childhood health histories. The ELSA fi elded their childhood health history between its wave 3 and wave 4 core interviews between February and August 2007. The ELSA used a stand-alone life-history computer assisted personal interview (CAPI) covering a variety of childhood circumstances and events as well as the prebaseline adult years. All ELSA respondents were eligible, and there was an 80 percent response rate (N ϭ 7,855). For the purposes of our analysis, the data from the life history questionnaire were combined with the data from the third wave the main interview, which was fi elded between June 2006 and March 2007. The HRS childhood health history was initially placed into an Internet survey in 2007 for those respondents who had Internet access and who agreed to be interviewed in that mode (N ϭ 3,641). The remainder of HRS respondents (N ϭ 12,337) received the same childhood health history as part of the 2008 core interview. 1 In addition to a subjective question rating their childhood health before age sixteen on the standard fi ve-point scale from excellent to poor, respondents in both surveys were asked about the occurrence of a set of common childhood illnesses. If the condition did exist, they were asked the age of fi rst onset. The list of childhood illnesses that were asked was very similar in the two surveys but not identical-some diseases were asked in one sur-vey but not the other. 2 Thus, we confi ne our analysis in this chapter only to childhood illnesses and conditions that were asked in both surveys. Even within this set of childhood conditions, there are differences in wording or inclusion that must be taken into account. The following childhood diseases have basically the same wording in both surveys-asthma, diabetes, heart trouble, chronic ear problems, severe headaches or migraines, and epilepsy or seizures. For the common childhood infectious diseases, HRS respondents were asked about mumps, measles, and chicken pox separately, while ELSA respondents were asked a single question about all infectious disease with the question wording mentioning these three diseases but also including polio and tuberculosis.
The biggest difference between the two surveys involves allergies and respiratory problems. In the HRS, respondents were asked about respiratory disorders, which included bronchitis, wheezing, hay fever, shortness of breath, and sinus infections, and were separately asked about any allergic conditions. The ELSA respondents were asked about allergies including hay fever and then separately about respiratory problems. Thus, hay fever shows up in a different category in the two surveys. The other difference of possible signifi cance concerns the category of emotional and psychological problems, which included two questions about depression and other emotional problems in the HRS and one question about emotional, nervous, or psychiatric problems in the ELSA.
In addition to any impact of these wording differences, the form in which the questions were asked also differed between the two surveys. The HRS respondents were asked separate questions about each condition, while the ELSA respondents were shown a showcard that contained a list of conditions and then asked to identify any that they may have had before age sixteen. The showcard format could lead to lower reported prevalence if respondents that had multiple conditions only identify a subset from showcards, while they would have answered in the affirmative to each of the questions individually had they been asked.
Comparing Childhood Health in England and the United States
Our fi rst descriptive analysis compares prevalences of childhood conditions that are more or less comparably defi ned in England and the United States using these two surveys. In addition to presenting overall prevalence in the two samples, we also stratifi ed the data by four broadly defi ned birth 2. For example, the following childhood conditions and diseases were asked in the ELSA but not in the HRS-broken bones and fractures; appendicitis; leukemia or lymphoma; cancer or malignant tumor. The following conditions were asked in the HRS but not in the ELSAdifficulty seeing even with glasses or prescription lenses; a speech impairment; stomach problems; high blood pressure; a blow to the head, head injury, or trauma severe enough to cause loss of consciousness or memory loss for a period of time.
cohorts-those born pre-1930, those born between 1930 and 1939, those born between 1940 and 1949, and those born in 1950 or after. Given the age selection of the HRS and ELSA respondents and the fact that both samples were refreshed with younger cohorts prior to the retrospective data collection (in 2006 for the ELSA and 2004 for the HRS), the youngest cohort of our sample contains only those born between 1950 and 1956.
Such age stratifi cation may reveal the nature of any secular trends in the prevalence of childhood diseases in the two countries. Given the reliance on recall for this data, however, considerable caution in interpreting any age patterns is advisable. One problem involves mortality selection if those with healthier childhoods live longer as they undoubtedly do. This is a selection effect that should become stronger at older ages.
Because these prevalence measures are based on recall, a second problem is that memory biases may be playing a role in these trends as well, and these may also be stronger at older ages. It is well established that memory typically declines with time from the event (Sudman and Bradburn 1974) . Salient events may suffer less from this type of memory decay, and memory of childhood happenings appear to be superior than for other times of life. Smith (2009a) shows that data from these recall histories on childhood health show similar age-cohort patterns to those collected from contemporaneous sources, for example.
The third and fi nal problem is the difficulty in separating cohort or time trends in true prevalence and incidence from improved detection or changing diagnostic thresholds. For most childhood diseases, there is very likely improved diagnosis and detection of childhood diseases over time, and, for some diseases, including mental illness, there may be some effect of a lowering of the threshold for diagnosis.
With these caveats in mind, table 9.1 presents the patterns revealed in the data on the prevalence of early life health conditions in England and the United States. The fi rst pattern of note is that across all ages in all nine childhood diseases, reported prevalence is actually higher in the United States than in England. In some cases, the prevalence rates are rather close (epilepsy, migraines, and asthma), but, in most cases, the rates in the United States are much higher, especially if we use relative risk as the metric for comparison. For example, there is a 45 percent higher risk of childhood allergies in the United States and a 29 percent higher risk of respiratory problems in the United States compared to England. Because England includes hay fever in allergies and the United States in respiratory, the relative risk difference between the two countries is even higher for allergies. Similarly, even though overall prevalence is low in both countries, relative risk of childhood heart disease and diabetes is much higher in the United States. Supporting evidence for an American excess of childhood disease compared to the English comes from Martinson, Teitler, and Reichman (2011) , who demonstrate using biomarker data from the National Health and Nutrition Examina-tion Survey (NHANES) and the Health Survey for England that in more contempory times there is also an American excess of childhood disease. It is important to note that their comparisons do not rely on recall.
The second salient pattern in these data is country differences in acrosscohort trends. While for most childhood diseases in both countries secular trends indicate growing prevalence over time, these secular trends appear to be much sharper in the United States than in England. For example, take respiratory diseases as the fi rst example-childhood prevalence is almost twice as high in the youngest birth cohorts compared to the oldest birth cohorts in table 9.1. The comparable fi gure for England is 9 percent higher.
We have discussed three potential difficulties in interpreting the crosscohort trends in table 9.1, namely mortality selection, imperfect recall, and secular trends in diagnosis. In principal, each of these effects could also be operating differentially in England and the United States and, hence, affecting our cross-country comparisons as well. Of the three, the one that is most amenable to investigation is mortality selection, and particularly the concern that cohort trends in mortality selection may be rather different in the two countries.
What would be most worrying would be higher rates of mortality prior to older ages in England. This might lead one to suppose that those who had the specifi c childhood conditions identifi ed in this table would be more likely to have died in England than in the United States, hence leading us to measure lower prevalence in England when we interview survivors of these cohorts many years later. In previous research, we have already documented lower mortality rates in England between ages fi fty and sixty-fi ve (Banks, Muriel, and Smith 2010) so to further our evidence on this issue we analyzed the Human Mortality Database data on survival to various ages for the two countries for all cohorts born between 1934 and 1958 (data on earlier cohorts are not available for the United States). 3 The analysis (presented in fi gure 9B.1 in appendix B) demonstrates that English cohorts were, in fact, more likely to survive to age fi fty than their US counterparts. If childhood disease is predictive of mortality prior to age fi fty, we may, if anything, be understating the true prevalence differences between the two countries at the time these cohorts were young. Interestingly, cohort trends in these survival probabilities are somewhat different across countries. For cohorts born from 1948 onward, the differences between countries in the likelihood of living to age fi fty becomes rather more substantial than for the earlier cohorts. Once again, this cohortspecifi c country divergence may be worrying for our analysis. But further investigation of this feature indicates that it is due to a sharp increase in the probability of living to age one in England after the Second World War for these later cohorts so that their survival rates were comparable to similar cohorts in the United States, while their predecessors had rather lower survival probabilities. 4 When we look at cohort trends in survival to age fi fty conditional on survival to age one, the pattern of cohort trends in the two countries is much more comparable with, in fact, an even greater advantage in favor of the English. Given that much of the diagnosis and onset of our childhood conditions will occur after age one, it is this last evidence that we think is most relevant for our purposes here.
Turning back to the ELSA and HRS childhood data that form the core of our analysis, table 9.2 compares later-life health outcomes in England and the United States, with the outcomes measured at or near to the time the retrospective data were collected (i.e., 2007 (i.e., in England and 2007 (i.e., to 2008 in the United States). We divide health outcomes into three groups-illnesses that we label major, those labeled minor, and those labeled "Barker." Major illness includes cancer, lung disease, stroke, angina, heart attack, and heart failure. Minor illness includes hypertension, diabetes, and arthritis. Barker illnesses include those related to heart disease and diabetes (angina, heart attack, heart failure, hypertension, and diabetes)-the diseases that are at the core of the Barker hypothesis linking early life and particularly in utero factors to later life health. For both countries, prevalence rates are stratifi ed by age and gender in table 9.2.
There are several salient patterns revealed in table 9.2. Not surprisingly, for all three disease categories, disease prevalence rises rapidly with age in both countries, with ages in the fi fties and sixties witnessing the most rapid rate of increase. Most important, across all three categories of illness used in table 9.2, Americans have much higher rates of disease than the English do. This pattern of excess illness in America compared to England when defi ned using these aggregated disease groupings appears to be true for men and women and accords with the various fi ndings on the more specifi c conditions and diseases that we have documented in our other research (Banks et al. 2006; Banks et al. 2010 ). Table 9 .3 presents our baseline ordinary least squares (OLS) models that attempt to isolate the salient country level differences in adult disease prevalence. These models contain only a quadratic in age (normalized so that age fi fty is zero and defi ned for expositional convenience as [(age-50)/ 10]), a gender dummy (male ϭ 1), a country dummy (US ϭ 1) and interactions of the US indicator variable with the age quadratic and gender. Not surprisingly, given the patterns revealed in table 9.2, we fi nd that all three disease groups increase with age at a decreasing rate, there is a small but statistically signifi cant male disease excess for major and Barker disease categories and a small (but again statistically signifi cant) female excess for minor diseases in England. 5 In terms of our main interest in country differences, we fi nd a statistically signifi cant common excess of disease in the United States. On average, and for the base case individuals (fi fty-year-old females), disease excess in the United States over England is 7.2 percentage points for major diseases, 14.5 percentage points for minor diseases, and 11.1 percentage points for Barker diseases. There is no strong evidence that this American disease excess differs across age and gender because the US interactions with these variables are not generally statistically signifi cant.
In the tables that follow, we expand the models in table 9.3 with additional groups of covariates with an eye toward examining the marginal impact of these additions on the country-level main effect differences in adult health status. The added covariates in table 9.4 include our few available common measures of childhood circumstances, parental background, and SES. These Notes: See text for more detailed descriptions of major, minor, and Barker illness categories. * * * Signifi cant at the 1 percent level. * * Signifi cant at the 5 percent level.
5. As always, these age patterns could partially refl ect cohort effects as well.
measures are (a) whether the mother or father of the respondent was dead at the time of the collection of the retrospective data and, if so, their age of death, which could be seen as measures of shared familial environment during the childhood years and/or genetic factors; (b) whether your SES was low during the childhood years based on father's occupation when you were sixteen years old; (c) adult height measured in centimeters (normalized to mean height-sixty-fi ve inches), an often used summary statistic to capture elements of the Barker hypothesis related to childhood nutrition. Once again, all variables in these models are interacted with a country dummy (US ϭ 1). These new variables in (a) and (c) could equally well be thought of as alternative indicators of childhood health. Parents and children shared genes forever and environment for at least decades so that parental deaths and/or date of death may pick up elements of health transmitted from parents to their children. Even more so, adult height is often used as a summary statistic for childhood health, or at least the nutritional components of childhood health and as a marker for Barker-related diseases. Examining the effects of new variables included in these models, all forms of adult disease are higher if either the mother or father of the respondent was dead at the time of the HRS or ELSA survey interview-an effect that is larger the younger the age at which parent died. The effect of these variables is not generally statistically signifi cantly different in the two countries though. Through either shared family environment or genetics, having a parent die at a younger age may indicate greater shared familial proneness to illness. Particularly for minor and Barker diseases, adult levels of disease are higher among those who were a member of a low-SES family during their childhood years. Finally, consistent with Barker's hypothesis, taller adults are also healthier adults. This association is especially strong for the Barker category of disease.
Once again and somewhat remarkably, very few of the interactions of variables with the US country indicator are statistically signifi cant with the exception of the US main effect, which still signals statistically signifi cantly higher levels of disease in America compared to England, on average. This US-level effect is only slightly smaller in table 9.4 compared to that obtained in the baseline models in table 9.3 indicating that this set of childhood SES or parental health measures do not contribute very much to "explaining" the country difference in adult health.
Our fi rst attempt to evaluate the contributory role of childhood health toward country level adult disease differences is contained in table 9.5, which adds to the set of variables in models in table 9.4 the summary childhood measure of subjective health status, that is, whether the respondents report that they had excellent or very good health as a child. The other covariates are not appreciably altered by this addition of childhood subjective health, so we will confi ne our discussion to the subjective childhood health measures. The estimated effect of being in excellent or very good health during one's childhood years is to lower the probability of all forms of adult disease. This association also appears to be statistically signifi cantly larger in the United States compared to England, but only for the major disease category.
However, the estimated overall average adult health differences between America and England in table 9.5 has remained essentially unchanged compared to those in table 9.4 and in the case of major illnesses has actually increased from 0.069 to 0.102. If childhood health problems raise the probability of adult health problems and if, as the data in table 9.1 indicate, there are more such problems in America than in England, how is it possible that these problems fail to explain the between-country health difference or even more perversely make them even larger? Table 9 .6 provides the answer by displaying country differences in excellent or very good subjective childhood health as a child by birth cohort in both England and the United States. In spite of the fact that the data in table 9.1 show that in almost all childhood diseases for all birth cohorts that Americans were sicker as children than their English counterparts, table 9.6 Notes: Base group is a 50-year-old female with mother and father alive, average height, high childhood SES, and good/fair/poor self-reported childhood health. See text for more detailed descriptions of major, minor, and Barker illness categories. * * * Signifi cant at the 1 percent level. * * Signifi cant at the 5 percent level. indicates that when asked to evaluate their childhood health on a subjective scale that Americans respond that their childhoods were healthier than the responses of the English would indicate about their own English childhood. The problem with using the childhood subjective health scale is actually the same as the problem with using the adult variant of these scales-given the same objective level of health on subjective scales, Americans will report themselves as healthier than the English (Banks et al. 2009; Kapteyn, Smith, and van Soest 2007) . For example, the fraction of ELSA respondents who report excellent or very good childhood health is 0.68, while in the HRS, it is 0.78-a ten-point differential in favor of the Americans. Because of this, and because being in excellent or very good health as a child is associated with better adult health in both countries, this will make the unexplained country adult health difference even larger.
Putting aside for a moment this problem of country differences in subjective scales, the within-country patterns revealed in table 9.6 are also of interest. The within-country gender differences in subjective childhood health are not large. However, there is a clear and very pronounced trend across cohort in both countries where subjective childhood health is reported to be better among the more recent cohorts. If we compare most recent cohorts in table 9.6 to the oldest cohorts, the increase in the fraction in excellent or very good health as a child is about 10 percentage points in both England and America. While it is possible that childhood health improved across these cohorts (contrary to the evidence on chronic diseases presented in table 9.1 above, and subject to the various caveats and especially to the role of improved diagnosis we identifi ed in the discussion of that table), the magnitude of this increase seems rather implausible, particularly in the presence of health survivor effects, which would tend to work across cohorts in the opposite direction. This points to another major puzzle in the reconciliation of secular trends in subjective and objective childhood health measures. Table 9 .7 extends our modeling of adult health in table 9.6 by adding the set of childhood disease indicators to the model as well as interactions of this set of childhood diseases with the US country indicator variable. Because the prevalence rates of some of these childhood diseases are low, we aggregated them into six groups. The six groups are ear problems, respiratory, allergies, asthma, rare diseases (childhood diabetes, epilepsy, emotional), and all others. Main effects and interactions with the US country indicator are included in the model. Because of the across-country scale comparability issue mentioned previously, the model estimated in table 9.7 does not include the subjective childhood health variable.
Once again, coefficients of other variables in the model are not significantly affected by adding childhood disease indicators. The diseases that appear to have most consistently statistically signifi cant main effects are ear problems, respiratory diseases, and rare diseases. Especially for major illness, transmission into poorer adult health appears to be stronger in the United States for rare diseases and for asthma. Table 9 .8 provides a summary of the estimated main effect American excess of disease from our models in tables 9.3 to 9.7. If we compare the estimates from table 9.7 with the age-adjusted "raw" country differences The comparable numbers for minor diseases is a 14.5 percentage point "raw" disease excess in America and an 11.1 percentage point adjusted excess so that 23 percent of the excess is explained. Finally, for the Barker diseases, the comparable numbers are 11.1 "raw" and 8.0 "adjusted" so that 28 percent of the American excess is explained.
As a fi nal note, it is instructive to consider the degree to which this explanation of the excess disease in the United States arises from the inclusion in the model of the indicators of prevalence of the specifi c childhood illnesses themselves as opposed to the interactions of these prevalence indicators with the US country dummy. To investigate this we ran a similar model to that presented in table 9.7 but with the childhood health country interaction terms excluded (full estimates presented in table 9A.1 in the appendix and estimates of the US intercept term presented in the fi nal row of table 9.8). On comparison of these results with those in the earlier tables, it is apparent that the main contribution to the reduction in both the size and statistical signifi cance of the US country effect arises from the inclusion of the interaction terms-while there is some role for the greater prevalence of childhood conditions in the United States, it is the differential impacts of these childhood conditions on later-life health outcomes in the United States that has the main effect on changing the coefficient on the US dummy variable. While these interaction terms are, of course, just another form of country effect, this does suggest that investigation of the mechanisms by which early-life health is transmitted to late-life disease outcomes in the two countries would be a promising avenue for future research. 
Conclusions
The analysis in this chapter uses comparable retrospective modules placed in the HRS and the ELSA-nationally representative surveys of the age fi fty-plus population in America and England, respectively-to show that the poorer adult health of older Americans in comparison to their English counterparts is also apparent right back in the childhood years of these cohorts. Furthermore, the transmission rates of childhood illnesses into poor health in midlife and older ages are also higher in America compared to England. However, these differences in childhood health conditions and the transmission rates of childhood health to adult health between the two countries only partially explain the poor health of older Americans compared to the English.
Of course, every partial answer raises yet another question. In this case, conditions in America appear to make people of all ages sicker than the English. This conclusion highlights a caution that age-specifi c answers to the question of why Americans are sicker may not serve as a useful guide to uncovering the more fundamental causes of this important question. Our research shows that the primary sources of the American excess in disease are not unique to midadulthood or old age but are more common throughout the age distribution of the two populations. Finally, it is worth noting that we are dealing in this research with the onset of disease rather than the treatment of disease so that the medical system and availability of health insurance are not likely to be the primary actors in this puzzle. This is particularly true given our use of a non-Hispanic white sample, so 95 percent of our American sample have access to health insurance. 
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